Home/All Molecules/Solifenacin

Solifenacin Range

Comprehensive Solifenacin portfolio for Franchise & Manufacturing.

Category
solifenacin
Total Formulations
7
Available Forms
Tablets

Expand Your Business with Our Multiple Divisions


Browse Solifenacin portfolio by Dosage Form


The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Solifenacin batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Solifenacin PCD Pharma Franchise Company

Solifenacin PCD Pharma Franchise Company

Cafoli Lifecare is a dependable Solifenacin PCD pharma franchise company in India, offering 7 Solifenacin formulations in tablet form. Manufacturing is carried out in WHO-GMP certified facilities with DCGI-approved compositions, giving partners a focused urology line that complements a wider BPH and bladder-care portfolio.

What is Solifenacin?

Solifenacin (usually supplied as solifenacin succinate) is a competitive muscarinic receptor antagonist with relative selectivity for the M3 receptors that mediate detrusor muscle contraction. By reducing involuntary detrusor activity it increases bladder capacity and lowers the urge to void, which is why it is used in overactive bladder syndrome. Pharmacological details are available on PubChem.

Therapeutic Applications of Solifenacin

Solifenacin is indicated for the symptomatic treatment of overactive bladder (OAB) with urge urinary incontinence, urgency and increased urinary frequency, and is also used in neurogenic detrusor overactivity. Prescriptions come chiefly from urologists and urogynaecologists, with additional prescribing by gynaecologists, geriatricians and consulting physicians.

Why Solifenacin is a High-Potential Molecule for Distributors

Overactive bladder is one of the most under-reported conditions in Indian practice: patients treat urgency and leakage as an embarrassing consequence of ageing and present late, which means the treated population is still growing rather than plateauing. Solifenacin benefits directly from that expansion. Its once-daily dosing and bladder selectivity improve adherence compared with older antimuscarinics, and since OAB is managed as a chronic condition, prescriptions repeat over many months. For a distributor, it is a specialist-anchored molecule with limited prescriber count but high per-patient lifetime value.

Why Choose Cafoli Lifecare

Cafoli Lifecare provides true district monopoly rights, WHO-GMP certified manufacturing, DCGI-approved compositions and a full promotional package including visual aids, samples, prescription pads, MR bags and doctor gifts. Over 1000+ partners across India already work with us.

References

  1. PubChem – Solifenacin compound record
  2. MedlinePlus – Solifenacin drug information
  3. PubMed – clinical literature on Solifenacin

Aceclofenac in Modern Clinical Practice

Our formulations of Solifenacin find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:


FAQ about Solifenacin in PCD Franchise

Start Your Solifenacin Franchise with Cafoli Lifecare

Ready to build your own Solifenacin distribution business? Cafoli Lifecare offers monopoly-based PCD pharma franchise rights, WHO-GMP certified manufacturing and complete promotional support. Call 9518447302 or email info@cafoli.in to check district availability and receive our latest price list.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

Cafoli Lifecare lists 7 Solifenacin tablet formulations, covering standard strengths used in overactive bladder therapy. The composition-wise list with packing and pricing is shared on enquiry.

Yes. Solifenacin is offered on a district monopoly basis, so only one Cafoli franchise partner operates in each territory. Availability is confirmed once your Drug License is verified.

Solifenacin is prescribed mainly by urologists and urogynaecologists, and also by gynaecologists, geriatricians and consulting physicians treating overactive bladder and urinary incontinence.

Overactive bladder is heavily under-treated in India because patients delay reporting symptoms, so the diagnosed pool is still expanding rather than saturated. Solifenacin is a once-daily bladder-selective antimuscarinic, and because OAB is a chronic condition, therapy continues for months, converting each patient into steady repeat demand from a compact group of specialist prescribers.

A valid Drug License and GST registration number are required to begin the appointment process with Cafoli Lifecare.